The global Metabolic Testing Market is estimated to be valued at Us$ 641.62 Mn in 2023 and is expected to exhibit a CAGR Of 7.6% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Metabolic testing products include metabolic carts, respiratory gas analyzers, ECG and body composition monitors. These products are used for measuring oxygen consumption, carbon dioxide production, lung function, energy expenditure and other parameters associated with metabolism. Increasing prevalence of lifestyle diseases such as diabetes and obesity has fueled the need for metabolic testing tools for diagnosis and monitoring.
Market key trends:
Wearable technology is emerging as one the key trends in the metabolic testing market. Various wearable devices are being launched that can monitor metabolic parameters continuously and seamlessly. For instance, fitness bands are integrated with heart rate monitors, pulse oximeters and global positioning system (GPS) to provide metrics on calorie burn, heart rate variability and other fitness indicators. Some smart watches are equipped with ECG monitors and have received FDA clearance for detecting abnormal heart rhythms. Further, clothing integrated with sensors is being developed that can track parameters like breathing rate, steps and energy expenditure. This is expected to drive wider adoption of metabolic testing devices.
The global metabolic testing market is segmented into product type, technology, end-user and region. Based on product type, the metabolic testing market is segmented into portable metabolic systems and laboratory-based metabolic testing systems. The portable metabolic systems segment dominated the global metabolic testing market in 2022 and is expected to continue its dominance over the forecast period. Portable metabolic systems are highly preferred by end users owing to their ease of use and portability.
The Global Metabolic Testing Market Demand is expected to reach US$ 1,007.56 Mn by 2030, expanding at a CAGR of 7.6% over the forecast period. Increasing prevalence of obesity and diabetes is expected to drive the market during the forecast period.
Regionally, North America dominated the global metabolic testing market in 2022 and is expected to continue its domination over the forecast period. This is attributed to growing prevalence of chronic metabolic diseases along with supportive reimbursement policies in the region. Asia Pacific is expected to witness fastest growth over the forecast period attributed to improving healthcare infrastructure and rising medical tourism in the region.
Key players operating in the metabolic testing market are COSMED srl, Vyaire Medical, Inc., Geratherm Medical AG, MGC Diagnostics Corporation, CORTEX Biophysik GmbH, General Electric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc., AEI Technologies, Inc., KORR Medical Technologies, Inc., Iworx Systems, GE Healthcare, Hologic, Inc, Geratherm Medical AG, and Parvo Medics. Among these, COSMED srl and Vyaire Medical, Inc. hold a significant share in the global market owing to their diverse product portfolio and strong geographical presence.